School of Medicine

Selected publications

  1. Woad KJ, Pearson SM, Harris SE, Gersak K, Shelling AN. Investigating the association between INHA promoter polymorphisms and premature ovarian failure. Fertility and Sterility, 2008, manuscript in press
  2. Grant VJ, Irwin RJ, Standley N, Shelling AN, Chamley L. Sex of bovine embryos may be related to mothers’ pre-ovulatory follicular testosterone. Biology of Reproduction, 2008, manuscript in press
  3. Ramachandran A, Black MA, Shelling AN and Love DR. Chapter 8, Microarrays: analysis of signalling pathways. Methods in Molecular Medicine, Vol. 141: Clinical Bioinformatics, (Trent R, Ed.) Human Press Inc., USA. 2008, p 115-130
  4. Woad KJ, Pearson S, Johnson NP and Shelling AN. Chapter 8c Inhibin alpha (INHα): The role of the inhibin gene in the development of premature ovarian failure. Advances in Fertility Studies and Reproductive Medicine.
  5. Kruger TF, Van Der Spuy Z, Kempers RD (Editors). Juta and Co Let, 2007, p219-226
  6. Chand AL, Ooi GT, Goodman S, Makanjee YM, Stanton P, Farnworth P, Fayad K, Harrison CA, Shelling AN, Robertson DM. Functional analysis of the human inhibin A257T mutation and its potential role in premature ovarian failure. Human Reproduction (2007) 22(12): 3241-3248
  7. Shelling AN, Ferguson LR. Genetic variation in human disease, and a new role for copy number variants. Mutation Research (2007) 622, 33-41
  8. Chung S-K, McCulley CH, Crawford J, Nel C, MacCormick JM, Mitchell E, Shelling AN, French J, Skinner JR, Rees MI. Spectrum of Long-QT Syndrome (LQTS) mutations in New Zealand. Heart Rhythm (2007) 4(10): 1306-14
  9. Chand AL, Shelling AN, Robertson DM, Harrison C. Mutational analysis of betaglycan/TGF-betaRIII in premature ovarian failure. Fertility and Sterility (2007) 87(1):210-212
  10. Watkins WJ, Harris SE, Craven M, Vincent AL, Winship IM, Gersak K, Shelling AN. An investigation into FOXE1 polyalanine tract length in premature ovarian failure and BPES. Molecular Human Reproduction (2006) 12 (3): 145-149
  11. Woad KJ, Watkins WJ, Prendergast D, Shelling AN. The genetic basis of premature ovarian failure. Australia and New Zealand Journal of Obstetrics and Gynaecology (2006) 46(3): 242-244
  12. Chand AL, Ponnampolam A, Harris SE, Winship IM, Shelling AN. Mutational analysis of GDF9 and BMP15 as candidate genes in premature ovarian failure. Fertility and Sterility (2006) 86(4): 1009-1012
  13. Watkins WJ, Umbers AJ, Woad KJ, Winship IM, Gersak K, Shelling AN. Mutational screening of FOXO3A and FOXO1A in premature ovarian failure. Fertility and Sterility (2006) 86(5): 1518-1521
  14. Vincent AL, Smale W, Sloan BH, Shelling AN. Type II Blepharophimosis and Bilateral Duane Syndrome associated with a FOXL2 mutation. Clinical Genetics (2005) 68(6): 520-3
  15. Harris SE, Chand AL, Winship IM, Gersak K, Nishi Y, Yanase T, Nawata H, Shelling AN. INHA promoter polymorphisms are associated with Premature Ovarian Failure. Molecular Human Reproduction (2005) 11(11): 779-784
  16. Chiu, W.C.C., Ericson, E.K.L., Sole, C.A., Shelling, A.N., Chamley, L.W. SPRASA, a novel sperm protein involved in immune mediated infertility. Human Reproduction (2004) 19(2): 243-249
  17. Gersak K, Harris S.E., Smale W, Shelling, A.N. A novel 30pb deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea. Human Reproduction (2004) 19(12): 2767-2770
  18. Sisco, B., Hagemann, L.J., Shelling, A.N., Pfeffer, P.L. Isolation of genes differentially expressed in dominant and subordinate bovine follicles. Endocrinology (2003) 144(9): 3904–3913
  19. Shelling, A.N., Schweder, P.M., During, M. Chapter 25. Principles of Gene Therapy Genetics in Endocrinology, John D. Baxter (Editor). Lippincott, Williams and Wilkins, Publishers. 2002, p 491-520
  20. Harris S.E., Chand A.L., Gersak, K, Aittomaki, K., Winship, I., Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure Molecular Human Reproduction (2002) 8(8): 729-733
  21. Francis-Thickpenny, K.M., Richardson, D.M., van Ee, C.C., Love, D.R., Winship, I.M., Baguley, B.C., Chenevix-Trench, G., Shelling, A.N. Analysis of the TGFß functional pathway in epithelial ovarian cancer. British Journal of Cancer, (2001), 85(5): 687-691
  22. Shelling, A.N. and Foulkes, W. Molecular genetics of ovarian cancer. Molecular Biotechnology, (2001), 19(1): 13-28 Shelling, A.N. X chromosome defects and premature ovarian failure. Australian & New Zealand Journal of Medicine (2000) 30, 3-5
  23. Odunsi, K. van Ee, C.C., Ganesan, T.S., and Shelling, A.N. Evaluation of the possible protective role of adeno-associated virus type 2 infection in HPV associated premalignant disease of the cervix. Gynecologic Oncology (2000) 78 (3), 342-345
  24. Shelling, A.N., Burton, K.A., Chand, AL, van Ee, C.C., France, J.T., Farquhar, C.M., Milsom, S.R., Love, D.R., Gersak, K, Aittomaki, K., and Winship, I. Inhibin: A Candidate Gene For Premature Ovarian Failure. Human Reproduction (2000) 15(12), 2644-2649
  25. Shelling, A.N., Foulkes, W.D. Molecular Genetics of Ovarian Cancer: technical overview. Chapter in Ovarian Cancer: Methods and Protocols, The Humana Press Inc., 2000, 39: p 273-290
  26. Kasprzak, L. Foulkes, W.D. and Shelling, A.N. Hereditary ovarian carcinoma. British Medical Journal (1999) 318, 786-789 Shelling, A.N. Role of p53 in drug resistance in ovarian cancer. The Lancet (1997) 349, 744-745
  27. Shelling, A.N., Cooke, I., Le Meuth, V.G. and Ganesan, T.S. Epithelial ovarian cancer: future prospects for treatment. New Zealand Medical Journal (1996) 109(1020) 131-132
  28. Shelling, A.N. Ovarian cancer in New Zealand Polynesians. New Zealand Medical Journal (1995) 108, 45 Shelling, A.N., Cooke, I. and Ganesan, T.S. The genetic analysis of ovarian cancer. British Journal of Cancer (1995) 72, 521-527
  29. Shelling, A.N., and Smith, M.G. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Therapy (1994) 1, 165-169